The use of complementary and alternative therapies in dogs and cats with cancer.

The use of complementary and alternative therapies in dogs and cats with cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The use of complementary and alternative therapies in dogs and cats with cancer. Abstract Text:

Susan E Lana,Lori R Kogan,Ken A Crump,J Terry Graham,Narda G Robinson,

The use of complementary and alternative medical therapies is becoming widespread. The objective of this study was to examine the use of complementary and alternative therapies in dogs and cats with cancer. The types of modalities used, the intended purpose for each modality, sources of information pet owners used, and the level of interest in these modalities were all evaluated. Information was obtained by written survey, and 254 owners agreed to participate. Complementary and alternative therapy use was commonplace, with 76% of surveyed owners reporting some use. When prayer for health reasons was excluded, the number of owners reporting use dropped to 65%. Nutritional supplements were the most commonly used therapy.

The use of complementary and alternative therapies in dogs and cats with cancer. Publishing Authors By Initials

SE Lana,LR Kogan,KA Crump,JT Graham,NG Robinson,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The use of complementary and alternative therapies in dogs and cats with cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the American Animal Hospital Associatio

VOLUME: 42

Page Numbers: 361-5

Journal Abbreviation:

ISSN: 1547-3317

DAY: 8

MONTH: 09

YEAR: 2006

The use of complementary and alternative therapies in dogs and cats with cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 415027

The use of complementary and alternative therapies in dogs and cats with cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The use of complementary and alternative therapies in dogs and cats with cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The use of complementary and alternative therapies in dogs and cats with cancer.

AFFILIATION: Animal Cancer Center, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, 300 West Drake, Fort Collins, Colorado 80523, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Am Anim Hosp Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The use of complementary and alternative therapies in dogs and cats with cancer Related Publications

• A basic program to determine outliers in biopharmaceutical analysis using the Nair criterion.
• Asymmetric fraunhofer diffraction from roller-blade slits.
• Co-localization of glycine and gaba immunoreactivity in interneurons in Macaca monkey cerebellar cortex.
• Comparative three-dimensional imaging of living neurons with confocal and atomic force microscopy.
• Detection of problem-drinkers in an emergency department using a breathalyser and questionnaire.
• Effects of intrauterine challenge with Leptospira interrogans serovar hardjo on fertility in cattle.
• Explanation of spin-lattice relaxation rates of spin labels obtained with multifrequency saturation recovery EPR.
• Geographic Information Systems and the Selection of Priority Areas for Control of Tsetse-transmitted Trypanosomiasis in Africa.
• HPLC procedure for the determination of some potential fluphenazine metabolites in urine.
• Identification of enzymatic degradation products of luteinizing hormone releasing hormone (LHRH)/[D-Ala6] LHRH in rabbit mucosal homogenates.
• Mitosis-specific mechanosensing and contractile-protein redistribution control cell shape.
• Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins.
• Monoamine oxidase inhibitors: a new generation.
• Mortality of intravenous drug users: attenders of the Wellington Drug Clinic, 1972-89.
• Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
• Oral neoplasms of children.
• Pinealectomy does not affect diurnal PER2 expression in the rat limbic forebrain.
• Protein kinase C-dependent remodeling of glutamate transporter function.
• Public and private intervention rates in obstetric practice.
• Pulmonary tuberculosis: the primary lesion; specific vs. nonspecific therapy.
• Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
• Spotlight on pioglitazone in type 2 diabetes mellitus.
• Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis.
• Technology can't replace compassion in health care.
• The absence of adaptive changes in tissue activities of glutathione-S-transferase, superoxide dismutase and catalase following selenium and vitamin E supplementation in subjects with low selenium status.
• The determination of nadolol in biological samples using high-performance liquid chromatography.
• The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses.
• The truth about colorectal cancer.
• The use of complementary and alternative therapies in dogs and cats with cancer.
• Vitamin E improves cell-mediated immunity in the burned mouse: a preliminary study.